Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesBiosimilars is the next big thing for generic cos: Biocon

SHOW NAMES

Trending Topics

Sensex Live KEC International Shares Solarworld Energy Solutions IPO Anand Rathi Share and Stock Brokers IPO Jaro Education IPO Subscription

business

Biosimilars is the next big thing for generic cos: Biocon

Biocon CMD Kiran Mazumdar-Shaw said the company‘s research efforts are focused on a number of programs that deliver drugs that women can benefit from.

first published: Mar 7, 2014 03:27 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347